FindTrial
Sign In

Estimation of cost value of anti-influenza agents based on the convenience for parents/guardians of child patients

Estimation of cost value of anti-influenza agents based on the convenience for parents/guardians of child patients - Estimation of cost value of anti-influenza agents based on the convenience for parents/guardians of child patients

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000044243
Enrollment
3000
Registered
2021-05-18
Start date
2021-05-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza

Interventions

None listed

Sponsors

Shionogi & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients of guardians of child patients who took oral or inhalation anti-influenza drugs at the age of 6-11 past three seasons (in 2018 or later).

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
Convenience of drugs: route and dosage form, frequency of administration, duration of administration, and costs—

Countries

Japan

Contacts

Public ContactKenji Kurazono

Shionogi & Co., Ltd. Medical Affairs Dept.

kenji.kurazono@shionogi.co.jp06-6485-5201

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026